BridgeBio Pharma Inc (BBIO)
24.11
-0.68
(-2.74%)
USD |
NASDAQ |
Nov 14, 16:00
24.62
+0.51
(+2.12%)
After-Hours: 04:53
BridgeBio Pharma Cash and Short Term Investments (Quarterly): 447.77M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 447.77M |
| March 31, 2024 | 519.69M |
| December 31, 2023 | 434.88M |
| September 30, 2023 | 543.26M |
| June 30, 2023 | 383.79M |
| March 31, 2023 | 491.29M |
| December 31, 2022 | 471.92M |
| September 30, 2022 | 591.98M |
| June 30, 2022 | 715.70M |
| March 31, 2022 | 671.23M |
| December 31, 2021 | 836.66M |
| September 30, 2021 | 599.61M |
| Date | Value |
|---|---|
| June 30, 2021 | 837.66M |
| March 31, 2021 | 919.12M |
| December 31, 2020 | 607.09M |
| September 30, 2020 | 710.68M |
| June 30, 2020 | 840.94M |
| March 31, 2020 | 905.18M |
| December 31, 2019 | 545.99M |
| September 30, 2019 | 536.05M |
| June 30, 2019 | 293.80M |
| March 31, 2019 | 373.03M |
| December 31, 2018 | 436.09M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
383.79M
Minimum
Jun 2023
919.12M
Maximum
Mar 2021
635.50M
Average
599.61M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 2.780B |
| Pfizer Inc | 9.952B |
| Vertex Pharmaceuticals Inc | 6.524B |
| PTC Therapeutics Inc | 1.013B |
| Bristol-Myers Squibb Co | 8.094B |